C57BL/6-Tg(CD19-cre/ERT2)1Jsv/Cnbc
Status | Available to order |
EMMA ID | EM:04499 |
International strain name | C57BL/6-Tg(CD19-cre/ERT2)1Jsv/Cnbc |
Alternative name | LC-1- hCD19CreERT2 |
Strain type | Transgenic Strains |
Allele/Transgene symbol | Tg(CD19-cre/ERT2)1Jsv |
Gene/Transgene symbol | Tg(CD19-cre/ERT2)1Jsv |
Information from provider
Provider | Sjef Verbeek |
Provider affiliation | Human Genetics, Leiden University Medical Center (LUMC) |
Genetic information | BAC transgenic strain with 75 Kb LC-1 BAC with 6.3 Kb human CD19 promoter region driving CreERT2 (tamoxifen inducible). |
Phenotypic information | B lymphocyte specific tamoxifen inducible Cre transgenic mouse strain. |
Breeding history | Generated with Bruce4 ES cells (C57BL/6) and further backcrossed 3 generations to C57BL/6J. Currently maintained as homozygous by intercrossing. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous C57BL/6J, wild-type C57BL/6J |
Stage of embryos | 2-cell |
Literature references
- Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.;Boross Peter, Breukel Cor, van Loo Pieter Fokko, van der Kaa Jos, Claassens Jill W, Bujard Hermann, Schönig Kai, Verbeek J Sjef, ;2009;Genesis (New York, N.Y. : 2000);47;729-35; 19621440
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).